| Dr Peter Quoc Le, DPM | |
|
2201 N Meridian Ave, Oklahoma City, OK 73107-2629 | |
| (405) 943-9820 | |
| (405) 947-6908 |
| Full Name | Dr Peter Quoc Le |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 26 Years |
| Location | 2201 N Meridian Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306827894 | NPI | - | NPPES |
| 200241830A | Medicaid | OK | |
| 731624991 | Other | OK | CIGNA GOVERNMENT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | POD209 (Oklahoma) | Primary |
| Provider Name | Meridian Clinic, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174767933 PECOS PAC ID: 7214081983 Enrollment ID: O20090814000041 |
News Archive
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
Using its first installed robot, VolitionRx has recently completed the analysis of a first NuQ® assay on the complete set of 4,800 blood samples for its large retrospective, symptomatic population colorectal cancer study in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark.
One in six countries is expected to have substantially high out-of-pocket spending as a proportion of total health expenditures by 2050, according to a new scientific study.
A new study by Cambridge University reveals that doctors treating life-threatening emergencies such as allergy attacks may give the wrong dosage of adrenaline (epinephrine) because of confusing labelling.
After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing. The vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Quoc Le, DPM 2201 N Meridian Ave, Oklahoma City, OK 73107-2629 Ph: (405) 943-9820 | Dr Peter Quoc Le, DPM 2201 N Meridian Ave, Oklahoma City, OK 73107-2629 Ph: (405) 943-9820 |
News Archive
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
Using its first installed robot, VolitionRx has recently completed the analysis of a first NuQ® assay on the complete set of 4,800 blood samples for its large retrospective, symptomatic population colorectal cancer study in collaboration with Hvidovre Hospital, University of Copenhagen, Denmark.
One in six countries is expected to have substantially high out-of-pocket spending as a proportion of total health expenditures by 2050, according to a new scientific study.
A new study by Cambridge University reveals that doctors treating life-threatening emergencies such as allergy attacks may give the wrong dosage of adrenaline (epinephrine) because of confusing labelling.
After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing. The vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.
› Verified 8 days ago
Dr. Terry M Nayfa, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3612 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-947-5492 Fax: 405-947-5532 | |
Timothy D Thomas, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. John Andrew Maupin Jr., DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 705 Nw 57th St, Oklahoma City, OK 73118 Phone: 405-550-0060 | |
David G. Wade Dpm Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3330 Nw 56th St, #600, Oklahoma City, OK 73112 Phone: 405-947-8041 | |
Alaina Janae Jones, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. Nicholas B Plants, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9315 S. Pennsylvania Ave, Suite A, Oklahoma City, OK 73159 Phone: 405-691-9004 Fax: 405-691-9003 | |
Peter Quoc Le Podiatrist Medicare: Medicare Enrolled Practice Location: 2201 N Meridian Ave, Oklahoma City, OK 73107 Phone: 405-943-9820 Fax: 405-947-6908 |